Company: WHWK
Filing Date: 2025-04-28
Form Type: DEF 14A
Source: 0001628280-25-020311
Chunk: 33

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-04-28
Form: DEF 14A
Chunk 33
---
 awarded for 2024.

(5) Amount includes: For Dr. Itri, reimbursement for monthly housing expenses and payment of consulting fees pursuant to a consulting agreement entered into between Dr. Itri and us, effective as of October 1, 2024; for Drs. Itri and Desai, payment of severance payments and payment of accrued paid time off in connection with their termination of employment with us; for Dr. Desai, $10,000 received as a retainer fee for service commencing on October 1, 2024 as a non-employee member of our Board pursuant to the Outside Director Compensation Policy.

<div align='center'>19</div>

(6) Dr. Lennon joined the company in October 2023 as our President and Chief Executive Officer and a member of our Board.

(7) Mr. Giacobello has served as our Chief Financial Officer since joining the company in November 2021. From March 14, 2023 to October 2, 2023, he also served as our interim President and Chief Executive Officer.

(8) Mr. Ball has served as our Chief Technical Operations Officer since March 2024 and served as our Chief Quality Officer and Senior Vice President, Manufacturing Operations from August 2022 to March 2024.

(9) Dr. Desai served as our Executive Chairman until October 1, 2024.

(10) Dr. Itri served as our Chief Medical Officer until October 1, 2024, following which we entered into a consulting agreement with Dr. Itri pursuant to which she provided 10 hours of consulting and advisory services per month in exchange for a monthly retain er of $8,000 through March 2025. Since April 2025, Dr. Itri remains a consultant on an as needed basis with an hourly rate.

<div align='center'>20</div>

#### Outstanding Equity Awards at December 31, 2024
The following table sets forth information regarding outstanding equity awards for each of the named executive officers as of December 31, 2024.

|                             |     | Option Awards |     |             |         |         |     |               |         |        |     |           |       |       |     |            |   |            |     | Stock Awards                                                |     |        |     |                                                                      |         |        |
| Name and Principal Position |     | Grant         
 Date (1)      |     | Number of   
 Securities  
 Underlying  
 Un